Logo image of INNV

INNOVAGE HOLDING CORP (INNV) Stock Fundamental Analysis

NASDAQ:INNV - Nasdaq - US45784A1043 - Common Stock - Currency: USD

4.14  -0.06 (-1.43%)

After market: 4.14 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to INNV. INNV was compared to 103 industry peers in the Health Care Providers & Services industry. INNV has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, INNV is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

INNV had negative earnings in the past year.
In the past year INNV had a positive cash flow from operations.
INNV had negative earnings in 4 of the past 5 years.
In multiple years INNV reported negative operating cash flow during the last 5 years.
INNV Yearly Net Income VS EBIT VS OCF VS FCFINNV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

1.2 Ratios

INNV has a worse Return On Assets (-5.82%) than 71.84% of its industry peers.
INNV has a worse Return On Equity (-13.12%) than 63.11% of its industry peers.
Industry RankSector Rank
ROA -5.82%
ROE -13.12%
ROIC N/A
ROA(3y)-4.08%
ROA(5y)-2.82%
ROE(3y)-7.87%
ROE(5y)-2.14%
ROIC(3y)N/A
ROIC(5y)N/A
INNV Yearly ROA, ROE, ROICINNV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

INNV has a worse Gross Margin (17.91%) than 65.05% of its industry peers.
INNV's Gross Margin has declined in the last couple of years.
INNV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.12%
GM growth 5Y-6.16%
INNV Yearly Profit, Operating, Gross MarginsINNV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 20

More info and screens

3

2. Health

2.1 Basic Checks

INNV does not have a ROIC to compare to the WACC, probably because it is not profitable.
INNV has more shares outstanding than it did 1 year ago.
INNV has more shares outstanding than it did 5 years ago.
INNV has a better debt/assets ratio than last year.
INNV Yearly Shares OutstandingINNV Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
INNV Yearly Total Debt VS Total AssetsINNV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 2.18 indicates that INNV is not a great score, but indicates only limited risk for bankruptcy at the moment.
INNV has a Altman-Z score (2.18) which is in line with its industry peers.
The Debt to FCF ratio of INNV is 4.81, which is a neutral value as it means it would take INNV, 4.81 years of fcf income to pay off all of its debts.
INNV has a better Debt to FCF ratio (4.81) than 68.93% of its industry peers.
A Debt/Equity ratio of 0.04 indicates that INNV is not too dependend on debt financing.
INNV has a Debt to Equity ratio of 0.04. This is in the better half of the industry: INNV outperforms 76.70% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 4.81
Altman-Z 2.18
ROIC/WACCN/A
WACC8.38%
INNV Yearly LT Debt VS Equity VS FCFINNV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 0.78 indicates that INNV may have some problems paying its short term obligations.
With a Current ratio value of 0.78, INNV is not doing good in the industry: 81.55% of the companies in the same industry are doing better.
INNV has a Quick Ratio of 0.78. This is a bad value and indicates that INNV is not financially healthy enough and could expect problems in meeting its short term obligations.
INNV has a worse Quick ratio (0.78) than 74.76% of its industry peers.
Industry RankSector Rank
Current Ratio 0.78
Quick Ratio 0.78
INNV Yearly Current Assets VS Current LiabilitesINNV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

5

3. Growth

3.1 Past

INNV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.27%, which is quite impressive.
INNV shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.18%.
INNV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.41% yearly.
EPS 1Y (TTM)27.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)12.18%
Revenue growth 3Y6.2%
Revenue growth 5Y10.41%
Sales Q2Q%12.99%

3.2 Future

INNV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 44.54% yearly.
INNV is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.43% yearly.
EPS Next Y-77.28%
EPS Next 2Y53.76%
EPS Next 3Y44.54%
EPS Next 5YN/A
Revenue Next Year12.69%
Revenue Next 2Y11.4%
Revenue Next 3Y11.43%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
INNV Yearly Revenue VS EstimatesINNV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
INNV Yearly EPS VS EstimatesINNV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -5 -10 -15

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for INNV. In the last year negative earnings were reported.
INNV is valuated quite expensively with a Price/Forward Earnings ratio of 81.18.
Compared to the rest of the industry, the Price/Forward Earnings ratio of INNV is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of INNV to the average of the S&P500 Index (21.76), we can say INNV is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 81.18
INNV Price Earnings VS Forward Price EarningsINNV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of INNV is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 34.95
EV/EBITDA N/A
INNV Per share dataINNV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

INNV's earnings are expected to grow with 44.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y53.76%
EPS Next 3Y44.54%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for INNV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INNOVAGE HOLDING CORP

NASDAQ:INNV (7/11/2025, 8:24:38 PM)

After market: 4.14 0 (0%)

4.14

-0.06 (-1.43%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)09-08 2025-09-08/amc
Inst Owners12.03%
Inst Owner Change0%
Ins Owners1.6%
Ins Owner Change0.14%
Market Cap558.94M
Analysts48
Price Target5.78 (39.61%)
Short Float %1.53%
Short Ratio8.36
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-409.8%
Min EPS beat(2)-527.45%
Max EPS beat(2)-292.16%
EPS beat(4)1
Avg EPS beat(4)-190.35%
Min EPS beat(4)-527.45%
Max EPS beat(4)62.77%
EPS beat(8)2
Avg EPS beat(8)-120.73%
EPS beat(12)3
Avg EPS beat(12)-113.22%
EPS beat(16)4
Avg EPS beat(16)-99.95%
Revenue beat(2)0
Avg Revenue beat(2)-1.34%
Min Revenue beat(2)-2.58%
Max Revenue beat(2)-0.1%
Revenue beat(4)1
Avg Revenue beat(4)-0.42%
Min Revenue beat(4)-2.58%
Max Revenue beat(4)2.09%
Revenue beat(8)4
Avg Revenue beat(8)-0.15%
Revenue beat(12)4
Avg Revenue beat(12)-1.01%
Revenue beat(16)6
Avg Revenue beat(16)-0.45%
PT rev (1m)-2.86%
PT rev (3m)-2.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-600.6%
EPS NY rev (1m)0.68%
EPS NY rev (3m)-97.3%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.46%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 81.18
P/S 0.67
P/FCF 34.95
P/OCF 21.72
P/B 2.35
P/tB 6.08
EV/EBITDA N/A
EPS(TTM)-0.16
EYN/A
EPS(NY)0.05
Fwd EY1.23%
FCF(TTM)0.12
FCFY2.86%
OCF(TTM)0.19
OCFY4.6%
SpS6.16
BVpS1.76
TBVpS0.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.82%
ROE -13.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.91%
FCFM 1.92%
ROA(3y)-4.08%
ROA(5y)-2.82%
ROE(3y)-7.87%
ROE(5y)-2.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.12%
GM growth 5Y-6.16%
F-Score6
Asset Turnover1.55
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 4.81
Debt/EBITDA N/A
Cap/Depr 45.45%
Cap/Sales 1.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.78
Quick Ratio 0.78
Altman-Z 2.18
F-Score6
WACC8.38%
ROIC/WACCN/A
Cap/Depr(3y)155.97%
Cap/Depr(5y)146.35%
Cap/Sales(3y)3.3%
Cap/Sales(5y)3.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y-77.28%
EPS Next 2Y53.76%
EPS Next 3Y44.54%
EPS Next 5YN/A
Revenue 1Y (TTM)12.18%
Revenue growth 3Y6.2%
Revenue growth 5Y10.41%
Sales Q2Q%12.99%
Revenue Next Year12.69%
Revenue Next 2Y11.4%
Revenue Next 3Y11.43%
Revenue Next 5YN/A
EBIT growth 1Y17.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year232.96%
EBIT Next 3Y74.52%
EBIT Next 5YN/A
FCF growth 1Y162.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y149.16%
OCF growth 3YN/A
OCF growth 5YN/A